SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-16-091952
Filing Date
2016-03-31
Accepted
2016-03-31 16:33:04
Documents
2
Period of Report
2016-03-31
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v435899_8k.htm 8-K 14891
2 EXHIBIT 99.1 v435899_ex99-1.htm EX-99.1 9637
  Complete submission text file 0001144204-16-091952.txt   25812
Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018
Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702
Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: 8-K | Act: 34 | File No.: 001-36288 | Film No.: 161543659
SIC: 2834 Pharmaceutical Preparations